Medications for Absence Epilepsy

40 results

  • Acetazolamide (acetazolamide)

    (Acetazolamide)
    McKesson Corporation dba SKY Packaging
    Usage: Acetazolamide is indicated as an adjunctive treatment for edema due to congestive heart failure, drug-induced edema, centrencephalic epilepsies, glaucoma (various types), and for preventing symptoms of acute mountain sickness in susceptible climbers during rapid ascent.

  • Acetazolamide (acetazolamide)

    (Acetazolamide)
    Bryant Ranch Prepack
    Usage: Acetazolamide is indicated as adjunctive treatment for edema from congestive heart failure and drug-induced causes, centrencephalic epilepsies, various types of glaucoma, and for preventing symptoms of acute mountain sickness in susceptible climbers.

  • Acetazolamide (acetazolamide)

    (acetaZOLAMIDE)
    Zydus Pharmaceuticals (USA) Inc.
    Usage: Acetazolamide is indicated as an adjunctive treatment for edema related to congestive heart failure and drug use, various forms of epilepsy, and glaucoma. It is also used to prevent or alleviate symptoms of acute mountain sickness in climbers.

  • Clonazepam (clonazepam)

    (Clonazepam)
    TYA Pharmaceuticals
    Usage: Clonazepam is indicated for the treatment of Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and as an adjunct for absence seizures in patients unresponsive to succinimides. It is also prescribed for panic disorder, characterized by unexpected panic attacks and associated behavioral changes. Long-term efficacy requires periodic reevaluation.

  • Clonazepam (clonazepam)

    (CLONAZEPAM)
    Alembic Pharmaceuticals Inc.
    Usage: Clonazepam orally disintegrating tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, as well as panic disorder with or without agoraphobia. Its long-term efficacy has not been systematically studied, prompting periodic reevaluation for ongoing use.

  • Clonazepam (clonazepam)

    (Clonazepam)
    RPK Pharmaceuticals, Inc.
    Usage: Clonazepam tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome, akinetic, myoclonic, and absence seizures unresponsive to succinimides. They are also effective for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks and related behavioral changes. Long-term effectiveness has not been systematically studied.

  • Clonazepam (clonazepam)

    (Clonazepam)
    Aurobindo Pharma Limited
    Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and as an adjunct for absence seizures. It is also used for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks. Long-term effectiveness has not been extensively studied.

  • Clonazepam (clonazepam)

    (CLONAZEPAM)
    DIRECT RX
    Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome and certain types of absence seizures. It is also approved for panic disorder, characterized by recurrent panic attacks. Long-term efficacy beyond nine weeks has not been systematically studied. Regular re-evaluation by a physician is advised.

  • Clonazepam (clonazepam)

    (Clonazepam)
    REMEDYREPACK INC.
    Usage: Clonazepam tablets are indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, as well as panic disorder with or without agoraphobia. Their efficacy in long-term use beyond nine weeks has not been systematically studied. Regular reassessment is recommended.

  • Clonazepam (clonazepam)

    (Clonazepam)
    Teva Pharmaceuticals USA, Inc.
    Usage: Clonazepam is indicated for the treatment of seizure disorders such as Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as for panic disorder, with or without agoraphobia. Its efficacy for long-term use beyond nine weeks has not been systematically studied.